Key takeaway
In 33 people with early Parkinson's disease, 12 weeks of twice-weekly dance classes produced no significant between-group differences in accelerometer-measured activity versus usual care. Stepping time and step count rose with moderate-to-large effect sizes (d = 0.72 and 0.91), but the study was too small to confirm them.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Daily activity falls as Parkinson's disease (PD) progresses, and dance has shown motor, non-motor and psychological benefits. The authors tested whether taking part in Dance for Parkinson's Disease classes was associated with changes in habitual physical activity, which had not been objectively measured.
Who and how
Quasi-experimental controlled study with pre and post testing of two parallel groups: 17 people in a dance group (age 65.8 ± 11.7 years) and 16 in a control group (67.0 ± 7.7 years), all cognitively intact and in early-stage PD (Hoehn & Yahr 1.6 ± 0.7 and 1.5 ± 0.8). The dance group did a one-hour Dance for Parkinson's Disease (DfPD) class twice weekly for 12 weeks; controls had treatment as usual. ActivPAL accelerometers measured activity for five consecutive days before and after, including sit/lie, standing and stepping time, transitions, daily steps and energy expenditure (MET-h/day).
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1No significant between-group differences were found for any ActivPAL outcome.
- 2Daily stepping duration and step count increased with moderate-to-large effect sizes (d = 0.72 and d = 0.91, respectively), but these did not reach significance in the group comparison.
- 3The authors conclude that dance participation did not significantly alter pre- to post-program habitual physical activity.
Limits & uncertainty
- 1Groups were not randomised (quasi-experimental), so differences between them could reflect who chose to dance.
- 2Only 33 participants (17 and 16) were studied, so the study was underpowered; the authors call for larger adequately powered trials.
- 3Participants were cognitively intact and in early-stage PD, and activity was monitored for just five days at each time point, so results may not apply to later-stage disease. This reading is based on the abstract only.
What to take from it
This small study could neither show that dance classes raise everyday activity in Parkinson's disease nor rule it out. Dance has other documented benefits, so it can be an enjoyable option, but whether it is suitable for you is a decision to make with your neurologist or physiotherapist.
Reading your own data
Daily steps and stepping time are what a wearable tracks, so they can show your own response to any new class. Compare multi-day averages on the same device and wear position, and expect natural day-to-day variation instead of reading one day.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Despite symptomatic therapies for PD, habitual physical activity inevitably declines as the disease progresses, leading to increased sedentary behavior. While dance programs have demonstrated a multitude of benefits including motor, non-motor, and psychological aspects, it has not yet been objectively determined if dance can improve habitual physical activity in people living with PD.
Aim
This study explored whether participation in Dance for Parkinson's Disease classes was associated with changes in habitual physical activity in people with PD.
Design
A quasi-experimental controlled efficacy study, with pre and post-testing of two parallel groups (dance versus control).
Population
Thirty-three participants with PD allocated to a dance group (DG; n = 17; age = 65.8 ± 11.7 years) or control group (CG: n = 16; age = 67.0 ± 7.7 years). Participants were cognitively intact (Addenbrooke's score: DG = 93.2 ± 3.6, CG = 92.6 ± 4.3) and in early stage PD (Hoehn & Yahr: DG = 1.6 ± 0.7, CG = 1.5 ± 0.8).
Methods
The DG undertook a one-hour Dance for Parkinson's Disease (DfPD®) -based class, twice weekly for 12 weeks (intervention). The CG had treatment as usual. ActivPAL™ accelerometers monitored habitual physical activity for five consecutive days pre-and post-intervention. Sit/lie duration (min), standing duration (min), stepping duration (min), sit/stand movements (count), stand/sit movements (count), daily step count, and energy expenditure (MET-h/day) were measured.
Results
No significant between-group differences were observed for any ActivPAL outcome. However, increases in daily stepping duration and step count demonstrated moderate-to-large effect sizes ( d = 0.72 and d = 0.91, respectively).
Conclusion
Participation in a dance for Parkinson's disease program did not significantly alter pre- to post-program habitual physical activity. Larger adequately powered trials are required to determine whether participation in dance programs can influence habitual physical activity in people with Parkinson's disease.
Sources & attribution
Effects of dance for Parkinson's disease on habitual physical activity: a quasi-experimental controlled study.
Kalyani HHN, Sullivan KA, Moyle GM, Brauer SG, Jeffrey ER, Kerr GK.
Frontiers in human neuroscience · 2026-10-13
DOI: 10.3389/fnhum.2026.1962191 ↗PubMed · 42947974 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

